Log in to save to my catalogue

Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofi...

Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10318875

Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1

About this item

Full title

Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1

Publisher

US: Oxford University Press

Journal title

Journal of the Endocrine Society, 2023-08, Vol.7 (8), p.bvad083-bvad083

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Context
In patients with neurofibromatosis type 1 (NF1), guidelines suggest screening for pheochromocytoma by metanephrine measurement and abdominal imaging, which may lead to the discovery of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and their differential diagnosis, gastrointestinal stromal tumors (GISTs). Other endoc...

Alternative Titles

Full title

Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10318875

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10318875

Other Identifiers

ISSN

2472-1972

E-ISSN

2472-1972

DOI

10.1210/jendso/bvad083

How to access this item